![Patricia Ohana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Ohana
Chief Tech/Sci/R&D Officer at The Hebrew University of Jerusalem
Patricia Ohana active positions
Companies | Position | Start | End |
---|---|---|---|
The Hebrew University of Jerusalem | Chief Tech/Sci/R&D Officer | - | - |
Career history of Patricia Ohana
Former positions of Patricia Ohana
Companies | Position | Start | End |
---|---|---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | - | 13/10/2010 |
Corporate Officer/Principal | 13/10/2010 | - |
Statistics
International
United States | 2 |
Israel | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
- Stock Market
- Insiders
- Patricia Ohana
- Experience